Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Issue of Equity

3 Sep 2008 07:00

RNS Number : 5963C
Imaginatik PLC
03 September 2008
Β 

ο»Ώ

Imaginatik Plc ("Imaginatik" or the "Company")

Issue of Equity

3 September 2008

Imaginatik plc (AIM: IMGK), a leading provider of collaborative innovation and problem-solving software and processes,Β is pleased to announce that it has raised approximately Β£222,000 before expenses by way of a conditional placing of 5,550,000 new Ordinary Shares of 0.0625p each (the "Placing Shares") at 4p per Placing Share from institutional placees.Β 

The proceeds of the Placing will be invested in Imaginatik's sales operation in theΒ UKΒ and US in order to increase follow-through sales to the Company's major Fortune 500 and FTSE 100 clients.

Application for admission of the Placing Shares ("Admission") has been made and is expected to occur on 9 September 2008. The Placing is conditional, amongst other things, on Admission becoming effective.

Following Admission, the Company will have 131,377,799 Ordinary Shares in issue. The Placing Shares represent approximately 4.22 per cent. of the enlarged issued share capital of the Company immediately following Admission and each of the Placing Shares will be credited as fully paid and free from all liens, equities, charges, encumbrances and other interests and will, when issued, rank in full for all dividends and distributions thereafter declared, made or paid after Admission and otherwise rank pari passu in all respects with, and carry the same voting and dividend rights as, the existing Ordinary Shares.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company.Β 

The number of Placing Shares does not exceed the number of Ordinary Shares which the directors of Imaginatik are currently able to allot and which can be allotted free from statutory rights of pre-emption under existing authorities from shareholders passed at the annual general meeting of the Company which was held on 10 July 2008.

The Placing is to be carried out on behalf of the Company by WH Ireland Limited ("WHI") on the terms of a placing agreement dated 2 September 2008 and which contains warranties and indemnities from the Company in relation to Admission, the Placing and certain aspects of the Company's financial and trading position. Under this agreement, WHI has agreed to act as agent of the Company to use its reasonable endeavours to procure subscribers for the Placing Shares. The Placing is not being underwritten.Β 

Mark Turrell, Chief Executive of Imaginatik, commented: "Following an improved start to the current financial year we felt the time was right to raise additional funds in order to capitalise on the current strong growth in the innovation and problem-solving market. Having achieved a market leading position, with an extensive blue-chip client base and award-winning software, this timely funding injection from our investors will enable an acceleration of our international growth plans creating additional long-term shareholder value."

For further information please contact:

Imaginatik plc

Tel: 020 7917 2975

Mark Turrell, CEO / Shawn Taylor, CFO

WH IrelandΒ Limited

Tel: 0121 265 6330

Tim Cofman / Katy Birkin

ICIS

Tel: 020 7651 8688

Caroline Evans-Jones / Mike Smith

About Imaginatik

Imaginatik is the leading provider of innovation and collaborative problem solving software and process to the world's leading companies. More than 100 clients rely on Imaginatik's software, consulting and research to enable their best-of-breed innovation activities.

Named as a World Economic Forum Technology Pioneer for 2008 and a finalist for the IBM Lotus Awards 2008 in the Best Industry Solution category, Imaginatik's software and consulting services have helped clients discover significant sources of additional revenue, as well as tangible cost savings, process improvements and increased product pipeline. Imaginatik is also committed to developing strategic solutions in the field of innovation, working with academic institutions such as theΒ LondonΒ BusinessΒ SchoolΒ and the Cass School of Business,Β London, as well as leading practitioners of corporate innovation.

For further information please visitΒ www.imaginatik.com


This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IOEEAXNAELSPEFE
Date   Source Headline
27th Nov 20137:00 amRNSHalf Yearly Report
24th Oct 20137:00 amRNSContract Win
10th Oct 201310:01 amRNSHolding(s) in Company
2nd Oct 20137:00 amRNSIssue of Equity
1st Oct 201310:03 amRNSTransaction in Own Shares/Director's Dealing
23rd Sep 20137:00 amRNSContract Win with Shell
18th Sep 20132:03 pmRNSResult of AGM
27th Aug 20131:50 pmRNSNotice of AGM
24th Jul 20137:00 amRNSFinal Results
8th Jul 20137:00 amRNSContract Win
1st Jul 20137:00 amRNSChange of Adviser
21st Jun 20137:00 amRNSBoard Changes
13th Jun 20137:00 amRNSConsultancy Update
31st May 20137:00 amRNSTotal Voting Rights
16th May 20131:03 pmRNSHolding(s) in Company
16th May 20137:00 amRNSHolding(s) in Company
13th May 201312:16 pmRNSResult of General Meeting
26th Apr 20134:52 pmRNSPublication of Circular
26th Apr 20137:00 amRNSProposed Placing
16th Apr 201312:20 pmRNSCapital Market Strategy Update
7th Feb 20132:25 pmRNSTrading Update
10th Dec 20127:00 amRNSContract Wins
22nd Nov 20127:00 amRNSShare Options
21st Nov 20127:00 amRNSHalf Yearly Report
25th Oct 20127:00 amRNSTrading Update
2nd Oct 20127:00 amRNSLitigation Conclusion
14th Sep 20121:02 pmRNSResult of AGM
14th Sep 20127:00 amRNSAGM Statement
23rd Aug 20127:00 amRNSNotice of AGM
4th Jul 201212:04 pmRNSHolding(s) in Company
2nd Jul 20122:22 pmRNSHolding(s) in Company
29th Jun 20123:30 pmRNSHolding(s) in Company
29th Jun 201212:12 pmRNSHolding(s) in Company
28th Jun 20121:36 pmRNSHolding(s) in Company
27th Jun 201211:20 amRNSResult of General Meeting
20th Jun 20121:41 pmRNSDirectorate Change
11th Jun 20128:30 amRNSDirector/PDMR Shareholding
11th Jun 20128:00 amRNSProposed Placing
11th Jun 20128:00 amRNSFinal Results
17th Apr 20127:00 amRNSTrading Update
17th Apr 20127:00 amRNSContract Wins
29th Feb 20127:00 amRNSContract with US Healthcare Services Provider
21st Feb 20121:45 pmRNSHolding(s) in Company
20th Feb 201212:54 pmRNSHolding(s) in Company
15th Feb 201212:16 pmRNSHolding(s) in Company
15th Feb 20127:00 amRNSShare Option Schemes
8th Feb 20127:00 amRNSIssue of Equity
3rd Feb 201211:39 amRNSHolding(s) in Company
2nd Feb 201210:49 amRNSHolding(s) in Company
30th Jan 20127:00 amRNSSenior Management Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.